Cue Biopharma to Present at the 2022 American Society of
BOSTON, May 26, 2022 (GLOBE NEWSWIRE) – Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient’s body, announced today it will give a poster presentation at… Read More »Cue Biopharma to Present at the 2022 American Society of